Abstract
This study evaluated first results of biphasic phosphate (BCP) ceramic granules with hydroxyapatite (HAp)/ β-tricalcium phosphate (TCP) ratio of 90/10 as bone substitute for reconstruction of the bone defects in orthopedic surgery, such as fracture and fracture non union treatment, primary and revision arthroplasty and chronic osteomyelitis. We evaluated twelve clinical cases of patients who had undergone surgeries with BCP implantation. Follow up period range from 2 to 8 months, on average 4.5 months. The classification of results was based on clinical and radiographic assessments. The size of defects ranged from 32 cm to 1 cm, average 6.42 cm, median 3 cm. The best results were obtained from patients after elective orthopedic procedures and patients with bone defects less than 3 cm.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 IFMBE
About this paper
Cite this paper
Petronis, S., Petronis, J., Zalite, V., Locs, J., Skagers, A., Pilmane, M. (2013). New Biphasic Calcium Phosphate in Orthopedic Surgery: First Clinical Results. In: Dekhtyar, Y., Katashev, A., Lancere, L. (eds) International Symposium on Biomedical Engineering and Medical Physics, 10-12 October, 2012, Riga, Latvia. IFMBE Proceedings, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34197-7_46
Download citation
DOI: https://doi.org/10.1007/978-3-642-34197-7_46
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-34196-0
Online ISBN: 978-3-642-34197-7
eBook Packages: EngineeringEngineering (R0)